Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Is LeMaitre Vascular Inc (LMAT) A Good Stock To Buy?

At Insider Monkey we track the activity of some of the best-performing hedge funds like Appaloosa Management, Baupost, and Tiger Global because we determined that some of the stocks that they are collectively bullish on can help us generate returns above the broader indices. Out of thousands of stocks that hedge funds invest in, small-caps can provide the best returns over the long term due to the fact that these companies are less efficiently priced and are usually under the radars of mass-media, analysts and dumb money. This is why we follow the smart money moves in the small-cap space.

LeMaitre Vascular Inc (NASDAQ:LMAT) investors should be aware of a decrease in hedge fund interest of late. LMAT was in 6 hedge funds’ portfolios at the end of the fourth quarter of 2018. There were 8 hedge funds in our database with LMAT positions at the end of the previous quarter. Our calculations also showed that LMAT isn’t among the 30 most popular stocks among hedge funds.

To the average investor there are dozens of gauges stock market investors put to use to evaluate stocks. A duo of the best gauges are hedge fund and insider trading interest. We have shown that, historically, those who follow the best picks of the top hedge fund managers can beat their index-focused peers by a very impressive margin (see the details here).

AQR CAPITAL MANAGEMENT

We’re going to go over the fresh hedge fund action regarding LeMaitre Vascular Inc (NASDAQ:LMAT).

How are hedge funds trading LeMaitre Vascular Inc (NASDAQ:LMAT)?

Heading into the first quarter of 2019, a total of 6 of the hedge funds tracked by Insider Monkey were long this stock, a change of -25% from the previous quarter. Below, you can check out the change in hedge fund sentiment towards LMAT over the last 14 quarters. So, let’s see which hedge funds were among the top holders of the stock and which hedge funds were making big moves.

LMAT_may2019

Of the funds tracked by Insider Monkey, Ken Griffin’s Citadel Investment Group has the largest position in LeMaitre Vascular Inc (NASDAQ:LMAT), worth close to $3.8 million, amounting to less than 0.1%% of its total 13F portfolio. On Citadel Investment Group’s heels is Marshall Wace LLP, led by Paul Marshall and Ian Wace, holding a $2.8 million position; less than 0.1%% of its 13F portfolio is allocated to the stock. Remaining peers that are bullish consist of Chuck Royce’s Royce & Associates, Cliff Asness’s AQR Capital Management and David Harding’s Winton Capital Management.

Because LeMaitre Vascular Inc (NASDAQ:LMAT) has faced bearish sentiment from the aggregate hedge fund industry, logic holds that there exists a select few money managers who sold off their positions entirely in the third quarter. It’s worth mentioning that Israel Englander’s Millennium Management dumped the biggest investment of all the hedgies followed by Insider Monkey, worth about $2.8 million in stock. Noam Gottesman’s fund, GLG Partners, also cut its stock, about $1.4 million worth. These transactions are intriguing to say the least, as total hedge fund interest fell by 2 funds in the third quarter.

Let’s also examine hedge fund activity in other stocks similar to LeMaitre Vascular Inc (NASDAQ:LMAT). These stocks are BP Prudhoe Bay Royalty Trust (NYSE:BPT), Arrow Financial Corporation (NASDAQ:AROW), Barings BDC, Inc. (NYSE:BBDC), and A10 Networks Inc (NYSE:ATEN). All of these stocks’ market caps resemble LMAT’s market cap.

Ticker No of HFs with positions Total Value of HF Positions (x1000) Change in HF Position
BPT 4 4888 0
AROW 3 11071 -1
BBDC 10 11904 1
ATEN 17 84026 2
Average 8.5 27972 0.5

View table here if you experience formatting issues.

As you can see these stocks had an average of 8.5 hedge funds with bullish positions and the average amount invested in these stocks was $28 million. That figure was $10 million in LMAT’s case. A10 Networks Inc (NYSE:ATEN) is the most popular stock in this table. On the other hand Arrow Financial Corporation (NASDAQ:AROW) is the least popular one with only 3 bullish hedge fund positions. LeMaitre Vascular Inc (NASDAQ:LMAT) is not the least popular stock in this group but hedge fund interest is still below average. This is a slightly negative signal and we’d rather spend our time researching stocks that hedge funds are piling on. Our calculations showed that top 15 most popular stocks) among hedge funds returned 24.2% through April 22nd and outperformed the S&P 500 ETF (SPY) by more than 7 percentage points. Unfortunately LMAT wasn’t nearly as popular as these 15 stock (hedge fund sentiment was quite bearish); LMAT investors were disappointed as the stock returned 16.2% and underperformed the market. If you are interested in investing in large cap stocks with huge upside potential, you should check out the top 15 most popular stocks) among hedge funds as 13 of these stocks already outperformed the market this year.

Disclosure: None. This article was originally published at Insider Monkey.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading...